ZIDOVUDINE for Hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,601 adverse event reports in the FDA FAERS database where ZIDOVUDINE was used for Hiv infection.
Most Reported Side Effects for ZIDOVUDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 1,816 | 27.0% | 210 | 280 |
| Virologic failure | 741 | 11.0% | 33 | 47 |
| Exposure during pregnancy | 575 | 8.6% | 38 | 61 |
| Drug resistance | 568 | 8.5% | 32 | 29 |
| Pathogen resistance | 552 | 8.2% | 16 | 31 |
| Viral mutation identified | 531 | 7.9% | 5 | 11 |
| Treatment failure | 409 | 6.1% | 50 | 17 |
| Maternal exposure during pregnancy | 395 | 5.9% | 25 | 71 |
| Anaemia | 380 | 5.7% | 67 | 162 |
| Premature baby | 367 | 5.5% | 58 | 70 |
| Lipodystrophy acquired | 313 | 4.7% | 1 | 42 |
| Death | 284 | 4.2% | 283 | 12 |
| Treatment noncompliance | 251 | 3.7% | 13 | 68 |
| Drug ineffective | 197 | 2.9% | 22 | 30 |
| Eyelid ptosis | 188 | 2.8% | 0 | 2 |
Other Indications for ZIDOVUDINE
Product used for unknown indication (874)
Prophylaxis against hiv infection (571)
Antiretroviral therapy (458)
Acquired immunodeficiency syndrome (105)
Maternal exposure timing unspecified (102)
Antiviral prophylaxis (64)
Hepatitis c (63)
Foetal exposure during pregnancy (60)
Antiviral treatment (58)
Perinatal hiv infection (53)
Other Drugs Used for Hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (27,672)
TENOFOVIR DISOPROXIL (19,662)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (15,794)
LAMIVUDINE (8,963)
DOLUTEGRAVIR (7,207)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (6,874)
RITONAVIR (6,739)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (5,840)
EFAVIRENZ (5,261)
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (4,854)